Insider Trading Activity - COLUMN GROUP III-A LP

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for COLUMN GROUP III-A LP

Goto 0, 1, Next

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2025-03-26 Purchase	2025-03-28 8:57 pm	Surrozen Inc.	SRZN	COLUMN GROUP III GP LP COLUMN GROUP III-A LP COLUMN GROUP III LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner	1,034,482	$11.6	$11,999,991	2,817,866 (Indirect)	View
2025-03-05 Purchase	2025-03-07 7:14 pm	Tenaya Therapeutics Inc.	TNYA	COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner	35,714,284	$0.7	$24,999,999	112,285,275 (Indirect)	View
2024-04-04 Purchase(A)	2024-04-17 4:14 pm	Surrozen Inc.	SRZN	COLUMN GROUP III GP LP COLUMN GROUP III-A LP COLUMN GROUP III LP 10% Owner	193,548	$15.5	$2,999,994	326,992 (Indirect)	View
2024-04-05 Sale	2024-04-08 8:04 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP 10% Owner	21,743,413	$0	$0	2,000 (Indirect Direct)	View
2024-04-04 Purchase	2024-04-08 4:23 pm	Surrozen Inc.	SRZN	COLUMN GROUP III GP LP COLUMN GROUP III-A LP COLUMN GROUP III LP 10% Owner	193,548	$15.5	$2,999,994	2,236,955 (Indirect)	View
2024-02-12 Purchase	2024-02-14 4:15 pm	Tenaya Therapeutics Inc.	TNYA	COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner	2,222,222	$4.5	$9,999,999	22,999,565 (Indirect)	View
2023-11-15 Purchase	2023-11-17 4:30 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	22,631	$0.6852	$15,507	21,743,413 (Indirect Direct)	View
2023-03-10 Purchase	2023-03-14 4:12 pm	Tenaya Therapeutics Inc.	TNYA	COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner	6,779	$2.5956	$17,596	20,777,343 (Indirect)	View
2023-02-08 Purchase	2023-02-10 4:32 pm	Tenaya Therapeutics Inc.	TNYA	COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner	1,500,000	$2.6	$3,900,000	20,770,564 (Indirect)	View
2023-01-30 Purchase	2023-02-01 4:50 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	184,272	$4.9986	$921,110	21,720,782 (Indirect Direct)	View
2023-01-23 Purchase	2023-01-25 4:35 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	9,900	$4.9994	$49,494	21,536,510 (Indirect Direct)	View
2023-01-19 Purchase	2023-01-23 4:25 pm	Tenaya Therapeutics Inc.	TNYA	COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner	69,739	$2.4979	$174,201	19,270,564 (Indirect)	View
2023-01-19 Purchase	2023-01-23 4:22 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	38,139	$4.9976	$190,603	21,526,610 (Indirect Direct)	View
2023-01-17 Purchase	2023-01-19 4:18 pm	Tenaya Therapeutics Inc.	TNYA	COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner	185,151	$2.5105	$464,827	19,200,825 (Indirect)	View
2023-01-12 Purchase	2023-01-17 4:34 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	5,378	$4.9466	$26,603	21,488,471 (Indirect Direct)	View
2023-01-10 Purchase	2023-01-12 4:37 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	309,070	$4.7865	$1,479,359	21,483,093 (Indirect Direct)	View
2022-12-12 Purchase	2022-12-14 4:29 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	300	$4.9767	$1,493	21,174,023 (Indirect Direct)	View
2022-11-21 Purchase	2022-11-23 4:17 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	40,327	$4.9988	$201,588	21,173,723 (Indirect Direct)	View
2022-11-21 Purchase	2022-11-23 4:12 pm	Tenaya Therapeutics Inc.	TNYA	COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner	9,615,384	$2.6	$24,999,998	19,015,674 (Indirect)	View
2022-11-03 Purchase	2022-11-07 4:20 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	139,148	$4.9187	$684,427	21,133,396 (Indirect Direct)	View
2022-10-27 Purchase	2022-10-31 5:19 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	76,877	$4.8602	$373,638	20,994,248 (Indirect Direct)	View
2022-10-25 Purchase	2022-10-27 6:55 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP Director 10% Owner	123,820	$4.8088	$595,428	20,917,371 (Indirect Direct)	View
2022-06-09 Purchase	2022-06-13 5:05 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	984,161	$13.5	$13,286,174	18,143,374 (Indirect Direct)	View
2022-06-02 Purchase	2022-06-06 4:44 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	34,200	$13.03	$445,739	18,110,897 (Indirect Direct)	View
2022-05-31 Purchase	2022-06-02 4:28 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	153,806	$13.46	$2,069,667	18,109,768 (Indirect Direct)	View
2022-05-26 Purchase	2022-05-31 5:02 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	22,911	$13.49	$309,035	18,104,692 (Indirect Direct)	View
2022-05-24 Purchase	2022-05-26 4:13 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	61,120	$13.42	$819,948	18,103,936 (Indirect Direct)	View
2022-05-19 Purchase	2022-05-23 4:14 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	39,700	$13.36	$530,454	18,101,919 (Indirect Direct)	View
2022-05-17 Purchase	2022-05-19 4:39 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	151,699	$13.33	$2,022,004	18,100,609 (Indirect Direct)	View
2022-05-13 Purchase	2022-05-17 4:22 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	162,531	$2.6327	$427,891	18,095,603 (Indirect Direct)	View
2022-05-11 Purchase	2022-05-13 5:32 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	166,350	$11.43	$1,902,032	18,090,240 (Indirect Direct)	View
2022-05-09 Purchase	2022-05-11 6:14 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	114,440	$10.95	$1,252,982	18,084,750 (Indirect Direct)	View
2022-01-24 Purchase	2022-01-26 7:14 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Director 10% Owner	849,701	$0	$0	18,080,973 (Indirect Direct)	View
2021-02-17 Sale	2021-02-19 5:31 pm	CONSTELLATION PHARMACEUTICALS INC	CNST	COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP COLUMN GROUP GP LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim 10% Owner	10,000	$36.95	$369,503	6,230,638 (Indirect Direct)	View
2020-11-16 Sale	2020-11-18 7:06 pm	Revolution Medicines Inc.	RVMD	COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP PONOI CAPITAL LP Ponoi Capital II LP Ponoi Management LLC Ponoi II Management LLC Kutzkey Tim GOEDDEL DAVID V 10% Owner	2,027,156	$36.4	$73,788,478	5,950,228 (Indirect Direct)	View
2020-09-01 Purchase	2020-09-03 5:32 pm	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP Svennilson Peter GOEDDEL DAVID V Director 10% Owner	64,089	$17.65	$1,131,358	18,242,932 (Indirect Direct)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2025-03-26 Expired	2025-03-28 8:57 pm	N/A N/A	Surrozen Inc.	SRZN	COLUMN GROUP III GP LP COLUMN GROUP III-A LP COLUMN GROUP III LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner	1,904,070	$0	2,817,866 (Indirect)	View
2024-04-05 Other	2024-04-08 8:04 pm	N/A N/A	NGM BIOPHARMACEUTICALS INC	NGM	COLUMN GROUP GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP Column Group IV LP Column Group IV-A LP Column Group IV GP LP TCG IV GP LLC Column Group Opportunity III LP Column Group Opportunity III GP LP 10% Owner	1,000	$0	2,000 (Indirect)	View
Ownership	2021-08-16 8:16 pm	N/A N/A	Surrozen Inc.	SRZN	COLUMN GROUP III GP LP COLUMN GROUP III-A LP COLUMN GROUP III LP 10% Owner	0	$0	9,414,795 (Indirect)	View
2021-08-03 Conversion	2021-08-04 6:34 pm	N/A N/A	Tenaya Therapeutics Inc.	TNYA	COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP 10% Owner	18,692,248	$0	4,985,570 (Indirect)	View
Ownership	2021-07-29 8:28 pm	N/A N/A	Tenaya Therapeutics Inc.	TNYA	COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP 10% Owner	0	$0	9,400,290 (Indirect)	View
2020-12-14 Exercise	2020-12-16 6:40 pm	N/A N/A	CONSTELLATION PHARMACEUTICALS INC	CNST	COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP COLUMN GROUP GP LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim 10% Owner	30,107	$1.55	6,240,638 (Direct)	View
2020-12-14 Exercise	2020-12-16 6:40 pm	N/A 2021-05-24	CONSTELLATION PHARMACEUTICALS INC	CNST	COLUMN GROUP L P COLUMN GROUP III LP COLUMN GROUP III-A LP COLUMN GROUP III GP LP COLUMN GROUP GP LP PONOI CAPITAL LP Ponoi Management LLC Ponoi Capital II LP Ponoi II Management LLC Kutzkey Tim 10% Owner	30,107	$0	6,240,638 (Direct)	View

(A) Indicate amendment filing.

Goto 0, 1, Next

Insider Trading & Ownership - COLUMN GROUP III-A LP